Back to Agenda
ST00: Current Status of Clinical Development for Depression. -Issues, Lesson Learns, Solutions-
Session Chair(s)
Marika Uchida
Undergraduate, Meiji Pharmaceutical University, School of Pharmacy, Japan
Moeka Yamanoi
Undergraduate, Meiji Pharmaceutical University, School of Pharmacy, Japan
Yuni Shimbori
School of Pharmacy, Nihon University, Japan
Speaker(s)
Tetsuo Nakabayashi, MD, PHD
Office of Medical Informatics and Epidemiology , Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Motoki Arakawa, PHD
Junior Associate Professor, School of Pharmacy, Nihon University , Japan
Katsuhiko Ichimaru
Review Director, Office of New Drug IV, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Hideki Maeda, PHD
Professor, Department of Regulatory Science, Meiji Pharmaceutical University, Japan
Jun Yamakami, PHD
Senior Manager, R&D Regulatory 1, Regulatory Affairs, Sanofi K.K., Japan
Saki Watanabe
Monitoring Group, Pfizer R&D Japan G.K., Japan
Ryohei Sato, MS
Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd., Japan
Minami Mori
CRA, Clinical Operations , IQVIA Services Japan K.K., Japan
Have an account?